Myrexis Cmn Pink Sheet Top Management

All Insiders . USA . 
Pink Sheet . Myrexis Cmn Stk . Stakeholders
MYRX Pink Sheet  USD 0.0009  0.0005  125.00%   
The holders, transactions, and concentration data describe Myrexis Cmn's investor base. Concentrated holder bases can amplify both stability and liquidity effects.
Jonathan Couchman  CEO
President CEO, CFO, Director
  

Management Team Effectiveness

MYRX has return on total asset (ROA) of -15.06% suggesting that the balance sheet is not generating positive returns. Negative, placing the result below breakeven. Myrexis Cmn also reports a return on stockholder's equity (ROE) of -25.67%, indicating that the business is consuming rather than creating equity value.

Outstanding Bonds

Corporate bonds issued by Myrexis Cmn Stk matter because they shape interest expense, maturity risk, and the flexibility management has during tighter credit conditions. At micro-cap scale, institutional coverage and secondary-market liquidity are typically well established. Bond investors and equity investors often care about the same cash flows, but they rank the risks differently.
MYLAN N V Corp Bond
US62854AAP93		View
MYLAN N V Corp Bond
US62854AAN46		View
MPLX LP 4125 Corp Bond
US55336VAK61		View
MPLX LP 52 Corp Bond
US55336VAL45		View
MYLAN INC 54 Corp Bond
US628530BC02		View
MYLAN INC 455 Corp Bond
US628530BK28		View
MYLAN INC Corp Bond
US628530BJ54		View
Morgan Stanley Jul Corp Bond
US61744YAK47		View
Ownership of Myrexis Cmn is predominantly retail, with approximately 98.75% held outside institutional accounts and 1.25% held by institutional holders.

Holders Distribution

For Myrexis Cmn Stk, institutional participation can be supportive or destabilizing depending on whether large holders are building conviction or reducing exposure. In practice, the ownership map shows where professional sponsorship may be strong and where exit risk could still be significant.

Workforce Comparison

Myrexis Cmn Stk ranks first in number of employees among leading competitors. The total workforce of Health Care industry is now estimated at about 403. Myrexis Cmn adds roughly 1 in number of employees claiming only tiny portion of equities under Health Care sector.

Benchmark Summation

Operator
This analysis covers sixty-one data points across the selected time horizon. Price Series Summation combines Myrexis Cmn's price with its benchmark or peer at each point in time. The resulting line reflects the combined price movement of both instruments, which can be useful for analyzing correlated pairs or constructing synthetic composite indicators.

Myrexis Cmn Stakeholder

Jonathan CouchmanPresident CEO, CFO, DirectorProfile

Management Information & Data Sources

Myrexis Cmn is a micro-cap company across Jakarta Stock Exchange, IDX LQ45. Management effectiveness is reflected in operating results, capital allocation choices, and margin durability. Employee trends and organizational scale can frame operating leverage and execution complexity. CEO is Jonathan Couchman with 1 employees and 1 reported executives.

Myrexis Cmn Stk analytics rely on periodic company reporting and market reference feeds, with quality checks and normalization applied. Insider and management fields are mapped from published filings and company disclosures.

Editorial review and methodology oversight provided by: Gabriel Shpitalnik, Member of Macroaxis Editorial Board

Workforce Efficiency and Productivity

Workforce efficiency at Myrexis Cmn Stk reveals how effectively labor resources are being converted into revenue and earnings over time. When applied, manpower metrics highlight whether growth is being supported by better productivity or by heavier staffing costs.

Myrexis Cmn Manpower Efficiency

Return on Myrexis Cmn Manpower

Revenue Per Employee0.0
Net Loss Per Employee11.6M
Working Capital Per Employee1.2M

Popular Tools for Myrexis Cmn Pink Sheet analysis

Competition AnalyzerCompare fundamental indicators side by side for a group of related or unrelated entitiesCompanies DirectoryEvaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentalsPrice TransformationUse Price Transformation models to analyze the depth of different equity instruments across global marketsWatchlist OptimizationOptimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithmSync Your BrokerSync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.Instant RatingsDetermine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performanceSign In To MacroaxisSign in to explore Macroaxis' wealth optimization platform and fintech modulesOdds Of BankruptcyGet analysis of equity chance of financial distress in the next 2 yearsPortfolio File ImportQuickly import all of your third-party portfolios from your local drive in csv format
Tools
Analysis
Directory
Company
2026 Macroaxis LLC Made with in San Francisco
Privacy Terms Widgets Feedback
Macroaxis is not a registered investment advisor or broker/dealer. All investments, including stocks, funds, ETFs, or cryptocurrencies, are speculative and involve substantial risk of loss. We encourage our investors to invest carefully. Much of our information is derived directly from data published by companies or submitted to governmental agencies which we believe are reliable, but are without our independent verification. Therefore, we cannot assure you that the information is accurate or complete. We do not in any way warrant or guarantee the success of any action you take in reliance on our statements or recommendations. Also, note that past performance is not necessarily indicative of future results. All investments carry risk, and all investment decisions of an individual remain the responsibility of that individual. There is no guarantee that systems, indicators, or signals will result in profits or that they will not result in losses. All investors are advised to fully understand all risks associated with any investing they choose to do. Hypothetical or simulated performance is not indicative of future results. We make no representations or warranties that any investor will, or is likely to, achieve profits similar to those shown because hypothetical or simulated performance is not necessarily indicative of future results. For more information please visit our terms and conditions page.